The Maurice Wilkins Centre’s Scientific Advisory Board comprises ten internationally recognised scientists and bio-entrepreneurs. The Board meets biennially to review the Centre’s research programme.
At its most recent review in 2019, the Board was of the unanimous view that the quality of the science undertaken by the MWC is outstanding.
Scientific Advisory Board
Professor Peter AndrewsAO, PhD, FTSE
Professor Peter Andrews served as Queensland's first Chief Scientist from 2003 to 2010. Before that, he led multidisciplinary scientific teams in several Australian universities and co-founded six biotechnology companies. He is currently chairman of Implicit Bioscience, Vast Bioscience, qutbluebox and the Magic Pudding Company.
He is a Fellow of the Royal Australian Chemical Institute, the Australian Academy of Technology and Engineering, and the Australian Institute of Company Directors. In 2004 he was appointed an Officer of the Order of Australia.
His book "Überpreneurs: how to create innovative global businesses and transform human societies", co-authored with social scientist Dr Fiona Wood, was published in 2014.
Dr Christopher B. CooperPhD
Dr Christopher B. (Chris) Cooper currently serves as Senior Director, Chemistry, at TB Alliance. After receiving his Ph.D. from Stanford University in 1988, Dr Cooper spent over ten years engaged in medicinal chemistry research at Pfizer, Inc. in both the US and UK.
In 1998, Chris joined Bristol-Myers Squibb, Inc. (BMS) to launch the Lead Synthesis Group spearheading the design and synthesis of drug-like medicinal chemistry arrays. Dr Cooper’s team was responsible for the pharmacological assessment of exploratory biological targets, and the advancement of early- and full-phase discovery programs.
Dr Cooper joined TB Alliance in 2009 where he oversees the Alliance’s global discovery and preclinical development chemistry activities. Chris has published over 70 peer-reviewed papers, and is co-inventor on over two dozen U.S. and PCT patents.